Published in Neurology on August 13, 2002
Common cellular and molecular mechanisms in obesity and drug addiction. Nat Rev Neurosci (2011) 1.93
BOLD fMRI deactivation of limbic and temporal brain structures and mood enhancing effect by transcutaneous vagus nerve stimulation. J Neural Transm (Vienna) (2007) 1.31
Weight loss during chronic, cervical vagus nerve stimulation in depressed patients with obesity: an observation. Int J Obes (Lond) (2007) 1.17
Role of the vagus nerve in the development and treatment of diet-induced obesity. J Physiol (2016) 0.96
Neuroimaging and neuromodulation approaches to study eating behavior and prevent and treat eating disorders and obesity. Neuroimage Clin (2015) 0.93
Gastric stimulation for weight loss. World J Gastroenterol (2012) 0.91
Electrical stimulation as treatment for obesity and diabetes. J Diabetes Sci Technol (2007) 0.88
Vagus nerve stimulation reduces body weight and fat mass in rats. PLoS One (2012) 0.87
Vagus nerve stimulation attenuates cerebral ischemia and reperfusion injury via endogenous cholinergic pathway in rat. PLoS One (2014) 0.85
Vagus nerve stimulation increases energy expenditure: relation to brown adipose tissue activity. PLoS One (2013) 0.84
Vagus nerve stimulation and emotional responses to food among depressed patients. J Diabetes Sci Technol (2007) 0.83
Vagus nerve stimulation and food intake: effect of body mass index. J Diabetes Sci Technol (2014) 0.81
An update on less invasive and endoscopic techniques mimicking the effect of bariatric surgery. J Obes (2012) 0.80
Novel insights into maladaptive behaviours in Prader-Willi syndrome: serendipitous findings from an open trial of vagus nerve stimulation. J Intellect Disabil Res (2015) 0.79
Contrasting effects of afferent and efferent vagal nerve stimulation on insulin secretion and blood glucose regulation. Physiol Rep (2016) 0.78
The effect of vagal nerve blockade using electrical impulses on glucose metabolism in nondiabetic subjects. Diabetes Metab Syndr Obes (2014) 0.77
Devices for the treatment of obesity: will understanding the physiology of satiety unravel new targets for intervention? J Diabetes Sci Technol (2008) 0.77
Closed-loop gastric electrical stimulation versus laparoscopic adjustable gastric band for the treatment of obesity: a randomized 12-month multicenter study. Int J Obes (Lond) (2016) 0.76
Eating disinhibition and vagal tone moderate the postprandial response to glycemic load: a randomised controlled trial. Sci Rep (2016) 0.75
Vagus Nerve Stimulation Exerts the Neuroprotective Effects in Obese-Insulin Resistant Rats, Leading to the Improvement of Cognitive Function. Sci Rep (2016) 0.75
Cystic fibrosis locus defined by a genetically linked polymorphic DNA marker. Science (1985) 5.81
A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med (1998) 4.31
Genetic linkage map of human chromosome 7 with 63 DNA markers. Proc Natl Acad Sci U S A (1987) 2.91
Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults. Neurology (1999) 2.72
Oxcarbazepine: double-blind, randomized, placebo-control, monotherapy trial for partial seizures. Neurology (1999) 2.61
Congenital porencephaly: MR features and relationship to hippocampal sclerosis. AJNR Am J Neuroradiol (1998) 2.08
Incidence and prevalence of epilepsy among older U.S. Medicare beneficiaries. Neurology (2012) 1.92
Placebo-controlled study of the efficacy and safety of lamotrigine in patients with partial seizures. U.S. Lamotrigine Protocol 0.5 Clinical Trial Group. Neurology (1993) 1.90
Racial disparities in the use of surgical treatment for intractable temporal lobe epilepsy. Neurology (2005) 1.81
Mutations in the X-linked filamin 1 gene cause periventricular nodular heterotopia in males as well as in females. Hum Mol Genet (2001) 1.80
Patient-oriented outcome assessment after temporal lobectomy for refractory epilepsy. Neurology (1999) 1.80
Bilateral parasagittal parietooccipital polymicrogyria and epilepsy. Ann Neurol (1997) 1.72
Intrinsic epileptogenesis of hypothalamic hamartomas in gelastic epilepsy. Ann Neurol (1997) 1.71
Efficacy of rapid IV administration of valproic acid for status epilepticus. Neurology (2005) 1.55
Significance of interictal temporal lobe delta activity for localization of the primary epileptogenic region. Neurology (1999) 1.49
Cognitive consequences of coexisting temporal lobe developmental malformations and hippocampal sclerosis. Neurology (1999) 1.48
Cerebral complications of angiography for transient ischemia and stroke: prediction of risk. Neurology (1979) 1.47
Characterization of mutations in the gene doublecortin in patients with double cortex syndrome. Ann Neurol (1999) 1.47
Patient-validated content of epilepsy-specific quality-of-life measurement. Epilepsia (1997) 1.41
Cortical abnormalities in epilepsy revealed by local EEG synchrony. Neuroimage (2007) 1.37
Bilateral porencephalic defect and bilateral perisylvian polymicrogyria. Brain Dev (1991) 1.37
Hippocampal sclerosis in temporal lobe epilepsy demonstrated by magnetic resonance imaging. Ann Neurol (1991) 1.34
Acute psychotic symptoms induced by topiramate. Seizure (1999) 1.34
Age-related metabolite changes and volume loss in the hippocampus by magnetic resonance spectroscopy and imaging. Neurobiol Aging (2000) 1.26
Analysis of granuloma formation in double cytokine-deficient mice reveals a central role for IL-10 in polarizing both T helper cell 1- and T helper cell 2-type cytokine responses in vivo. J Immunol (1997) 1.23
Improved health care resource utilization following video-EEG-confirmed diagnosis of nonepileptic psychogenic seizures. Seizure (1998) 1.16
Familial perisylvian polymicrogyria: a new familial syndrome of cortical maldevelopment. Ann Neurol (2000) 1.13
Modulation of cerebral GABA by topiramate, lamotrigine, and gabapentin in healthy adults. Neurology (2002) 1.12
Relative utility of 1H spectroscopic imaging and hippocampal volumetry in the lateralization of mesial temporal lobe epilepsy. Neurology (1998) 1.11
Magnetic resonance spectroscopic imaging in temporal lobe epilepsy: neuronal dysfunction or cell loss? Arch Neurol (2001) 1.11
Magnetic resonance imaging in childhood intractable partial epilepsies: pathologic correlations. Neurology (1993) 1.09
Postmarketing experience with topiramate and cognition. Epilepsia (2001) 1.08
Subjective versus objective memory change after temporal lobe epilepsy surgery. Neurology (1999) 1.06
Predictive value of magnetic resonance imaging in temporal lobe epilepsy surgery. Arch Neurol (1993) 1.06
Proton nuclear magnetic resonance spectroscopic imaging of human temporal lobe epilepsy at 4.1 T. Ann Neurol (1995) 1.06
Epilepsy surgery outcome: comprehensive assessment in children. Neurology (1997) 1.05
The safety of rapid valproic acid infusion. Epilepsia (2000) 1.04
Adult myoclonic epilepsy: a distinct syndrome of idiopathic generalized epilepsy. Neurology (2000) 1.04
Cortical dysplasia in temporal lobe epilepsy: magnetic resonance imaging correlations. Ann Neurol (1991) 1.04
Topiramate increases cerebral GABA in healthy humans. Neurology (1998) 0.99
Proton spectroscopic imaging at 4.1 tesla in patients with malformations of cortical development and epilepsy. Neurology (1997) 0.97
Bullous pemphigoid antigen (BPAG1): cDNA cloning and mapping of the gene to the short arm of human chromosome 6. Genomics (1990) 0.96
Wisconsin Card Sorting performance in patients with temporal lobe epilepsy: clinical and neuroanatomical correlates. Epilepsia (2000) 0.96
Multimodality MRI in mesial temporal sclerosis: relative sensitivity and specificity. Neurology (1997) 0.96
Predictive value of 1H MRSI for outcome in temporal lobectomy. Neurology (1999) 0.96
Regulation of tyrosine hydroxylase activity in rat PC12 cells by neuropeptides of the secretin family. Mol Pharmacol (1989) 0.95
Late-onset variant of Huntington's chorea. South Med J (1983) 0.95
Frequency of epilepsy in patients with psychogenic seizures monitored by video-EEG. Neurology (2003) 0.95
Individual memory change after anterior temporal lobectomy: a base rate analysis using regression-based outcome methodology. Epilepsia (1998) 0.94
Quantitative MRI in temporal lobe epilepsy: evidence for fornix atrophy. Neurology (1999) 0.94
Vagus nerve stimulation for treatment of partial seizures: 3. Long-term follow-up on first 67 patients exiting a controlled study. First International Vagus Nerve Stimulation Study Group. Epilepsia (1994) 0.93
Effect of electrosurgical technique on wound healing and early complication rate following abdominal dermolipectomy. Ann Plast Surg (1996) 0.93
Transient focal ischemia in subhuman primates. Neuronal injury as a function of local cerebral blood flow. J Neuropathol Exp Neurol (1983) 0.93
Temporal lobe developmental malformations and epilepsy: dual pathology and bilateral hippocampal abnormalities. Neurology (1998) 0.92
Recurrent mutations in DNAJC5 cause autosomal dominant Kufs disease. Clin Genet (2012) 0.92
Human nidogen: complete amino acid sequence and structural domains deduced from cDNAs, and evidence for polymorphism of the gene. DNA (1989) 0.91
Altered brain sodium channel transcript levels in human epilepsy. Brain Res Mol Brain Res (1996) 0.91
Ambulatory EEG monitoring. J Clin Neurophysiol (1999) 0.91
Cells and cytokines in the pathogenesis of MAIDS, a retrovirus-induced immunodeficiency syndrome of mice. Springer Semin Immunopathol (1995) 0.90
Brainstem auditory evoked responses in brainstem infarction. Stroke (1985) 0.90
Familial myopathy with changes resembling inclusion body myositis and periventricular leucoencephalopathy. A new syndrome. Brain (1988) 0.90
Bilateral hippocampal atrophy: consequences to verbal memory following temporal lobectomy. Neurology (2001) 0.89
Metabolic networks in epilepsy by MR spectroscopic imaging. Acta Neurol Scand (2012) 0.88
Comparative cognitive effects of carbamazepine and gabapentin in healthy senior adults. Epilepsia (2001) 0.86
Occipitoparietal epilepsy, hippocampal atrophy, and congenital developmental abnormalities. Epilepsia (2000) 0.86
MRI extrahippocampal volumes and visual memory: correlations independent of MRI hippocampal volumes in temporal lobe epilepsy patients. J Int Neuropsychol Soc (1999) 0.86